We use cookies to give you the best personal experience on our website. If you continue to use our site without changing your cookie settings, you agree we may place these cookies on your device. You can change your cookie settings at any time but if you do , you may lose some functionality on our website . More information can be found in our privacy policy.
Please provide more information.
Stylus no longer supports Internet Explorer 7, 8 or 9. Please upgrade to IE 11, Chrome, Safari, Firefox or Edge. This will ensure you have the best possible experience on the site.
Brief Published: 2 Aug 2012

Ingestible Sensors Approved by FDA

Extra

Californian company Proteus Digital Health’s ingestible sensors have been granted medical approval by the US Food and Drug Administration for use as smart pills.

Once swallowed, the sensors react to stomach fluid and release a unique electrical signature that is recorded by a special patch worn on the patient’s skin. The data gathered is relayed to a smartphone, allowing patients or healthcare professionals to track medication compliance using an app.

Read more about Proteus Digital Health’s ingestible sensors and the emergence of preventative medicine in Sensing Health.

Proteus Digital Health

related reports
More
PANTONE®TPX
COATED
RAL
RGB
HEX
NCS